HARA Hiroaki
Academic Assembly School of Medicine and Health Sciences Institute of Medicine
School of Medicine Department of Urology
Assistant Professor
Researcher Information
Research activity information
Paper
- Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma
Takahashi M, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Kawasaki Y, Kato T, Tatarano S, Masui K, Nakamura E, Kaneko T, Miyake M, Kitano G, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J.
Clin Genitourin Cancer, 23(3), Jun. 2025, Refereed - Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N
Jpn J Clin Oncol, 55(5), 531-538, Apr. 2025, Refereed - Development of Bilayered Bone Marrow-derived Cell-Gelatin Grafts for Augmentation Cystoplasty and Reconstruction of Bladder Tissues in Rats
Inoue, Yoshihiro; Imamura, Tetsuya; Ogawa, Noriyuki; Hara, Hiroaki; Matsumoto, Yuki; Ueno, Manabu; Minagawa, Tomonori; Ogawa, Teruyuki; Ishizuka, Osamu
The Shinshu Medical Journal, 71(3), 167-177, 10 Jun. 2023
- A pilot prospective randomized trial with cancer fatigue scale and Juzentaihoto for cancer-related fatigue during cisplatin-based chemotherapy for advanced urothelial carcinoma
DOMEN Takahisa;MINAGAWA Tomonori;HARA Hiroaki;SUZUKI Ataru;OGAWA Teruyuki;ISHIZUKA Osamu
The Shinshu Medical Journal, 70(5), 275-284, 10 Oct. 2022
